Pulmonary hypertension: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (Started treatment section) |
imported>Robert Badgett (→Treatment: started 'Perioperative care') |
||
| Line 11: | Line 11: | ||
* [[Prostaglandin]]s, such as [[iloprost]], [[treprostinil]], or [[epoprostenol]]. | * [[Prostaglandin]]s, such as [[iloprost]], [[treprostinil]], or [[epoprostenol]]. | ||
* [[Endothelin]] receptor antagonists such as [[bosentan]]. | * [[Endothelin]] receptor antagonists such as [[bosentan]]. | ||
===Perioperative care=== | |||
The [[preoperative care]] and [[perioperative care]] (including [[intraoperative care]] and [[postoperative care]]) has been reviewed.<ref name="pmid19558745">{{cite journal| author=Hill NS, Roberts KR, Preston IR| title=Postoperative pulmonary hypertension: etiology and treatment of a dangerous complication. | journal=Respir Care | year= 2009 | volume= 54 | issue= 7 | pages= 958-68 | pmid=19558745 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&retmode=ref&cmd=prlinks&id=19558745 }} </ref><ref name="pmid17576968">{{cite journal| author=Lai HC, Lai HC, Wang KY, Lee WL, Ting CT, Liu TJ| title=Severe pulmonary hypertension complicates postoperative outcome of non-cardiac surgery. | journal=Br J Anaesth | year= 2007 | volume= 99 | issue= 2 | pages= 184-90 | pmid=17576968 | |||
| url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&retmode=ref&cmd=prlinks&id=17576968 | doi=10.1093/bja/aem126 }} </ref> | |||
==References== | ==References== | ||
<references/> | <references/> | ||
Revision as of 11:36, 11 June 2010
- The content on this page originated on Wikipedia and is yet to be significantly improved. Contributors are invited to replace and add material to make this an original article.
In medicine, pulmonary hypertension is "increased vascular resistance in the pulmonary circulation, usually secondary to heart diseases or lung diseases."[1]
Diagnosis
The echocardiogram may be more than 10 mm/Hg in error in half of cases.[2]
Treatment
For all patients, consider:
- Inhibitors of phosphodiesterase type 5 (PDE-5), such as sildenafil.
For patients with New York Heart Association (NYHA) class IV symptoms inspite of calcium-channel antagonists, consider:
- Prostaglandins, such as iloprost, treprostinil, or epoprostenol.
- Endothelin receptor antagonists such as bosentan.
Perioperative care
The preoperative care and perioperative care (including intraoperative care and postoperative care) has been reviewed.[3][4]
References
- ↑ Anonymous (2024), Pulmonary hypertension (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Fisher MR, Forfia PR, Chamera E, et al (April 2009). "Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension". Am. J. Respir. Crit. Care Med. 179 (7): 615–21. DOI:10.1164/rccm.200811-1691OC. PMID 19164700. Research Blogging.
- ↑ Hill NS, Roberts KR, Preston IR (2009). "Postoperative pulmonary hypertension: etiology and treatment of a dangerous complication.". Respir Care 54 (7): 958-68. PMID 19558745.
- ↑ Lai HC, Lai HC, Wang KY, Lee WL, Ting CT, Liu TJ (2007). "Severe pulmonary hypertension complicates postoperative outcome of non-cardiac surgery.". Br J Anaesth 99 (2): 184-90. DOI:10.1093/bja/aem126. PMID 17576968. Research Blogging.